Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00669266 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Adrenal Tumors - Pathogenesis and Therapy

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv13
  2. Study completion date: Dec 2030 to Dec 2032v12
  3. Re-verified, no change to tracked fieldsv11
  4. Study Status, Referencesv10
  5. Primary completion date: Dec 2022 to Dec 2030
    • Study completion date: Dec 2024 to Dec 2030
    v9
Show 7 earlier versionsHide 7 earlier versions
  1. 2 versions Re-verified since Oct 28, 2016, no change to tracked fieldsv7-v8
  2. Primary completion date: Dec 2012 to Dec 2022
    • Study completion date: Dec 2013 to Dec 2024
    v6
  3. Primary completion date: Dec 2011 to Dec 2012
    • Study completion date: Dec 2012 to Dec 2013
    v5
  4. Re-verified, no change to tracked fieldsv4
  5. Primary completion date: Dec 2010 to Dec 2011
    • Study completion date: Dec 2010 to Dec 2012
    v3
  6. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options for malignant tumors are poor. The current study investigates different aspects of the pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with adrenocortical carcinoma.
Trial Details
NCT Number NCT00669266
Lead Sponsor University of Wuerzburg
Collaborators: Deutsche Krebshilfe e.V., Bonn (Germany), German Federal Ministry of Education and Research
Conditions
(from sponsor)		 Adrenal Tumors, Adrenocortical Carcinoma, Cushing Syndrome, Conn Syndrome, Pheochromocytoma
Related terms Adrenal Gland Neoplasms, Adrenocortical Carcinoma, Cushing Syndrome, Hyperaldosteronism, Pheochromocytoma
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov